Open AccessPost- COVID-19 multisystem inflammatory syndrome in children
Author(s) -
Varsha Dalal,
Rincy Anna Reji,
Ruchika Jain,
Sreelakshmi S Mohandas,
Prasad Bali
Publication year - 2021
Publication title -
indian journal of immunology and respiratory medicine
Language(s) - English
Resource type - Journals
ISSN - 2456-012X
DOI - 10.18231/j.ijirm.2021.053
Subject(s) - medicine , methylprednisolone , covid-19 , pediatrics , population , cardiogenic shock , systemic inflammatory response syndrome , intensive care medicine , sepsis , disease , myocardial infarction , infectious disease (medical specialty) , environmental health
COVID-19 is a severe acute respiratory infection affecting worldwide population. There are many cases of complications after the COVID exposure occurring nowadays. One among is Post-COVID-19 Multisystem Inflammatory Syndrome in Children (MIS-C). As per CDC report till March 1, 2021, 2617 cases of MIS-C were meeting the definite case criteria and among 33 death cases were reported. Here we report a case of COVID-19 associated Multi-system inflammatory syndrome in a child (MIS-C) interpreted with WHO case definition criteria. The patient was a 7-year-old boy, with initial presentation of moderate fever, non-itchy red blanching rashes, breathlessness, later progressed to cardiogenic shock accompanied by positive SARS-CoV-2 antigen result. The emergency cardiogenic shock treatment protocol was followed with initial stabilization and resuscitation strategy. He was successfully managed by three days of IV Immunoglobulin 2g/kgand Methylprednisolone 2mg/kg/day therapy along with other supportive treatments. The patient was discharged after 20 days of hospital stay with improved health condition. Our case report will strengthen the exposure-outcome relations between the coronavirus infection and MIS-C, moreover the strategies carried out in our case will be a future direction for the effective management of MIS-C.